Neil D. Palmisiano, MD, MS
- System Leader for Leukemia, RWJBarnabas Health
- Deputy Director of Phase I Therapeutics for Hematologic Malignancies
- Co-Medical Director of the Office of Human Research Services, Rutgers Cancer Institute
Having spent the last decade specializing in the care of patients with acute leukemias and myelodysplastic syndrome, I am excited and honored to bring my experience treating this patient population to Rutgers Cancer Institute of New Jersey as the System Leader for Leukemia at RWJBarnabas Health and Deputy Director of Phase I Therapeutics for Hematologic Malignancies and Co-Medical Director of the Office of Human Research Services.
I completed my residency and fellowship at Thomas Jefferson University in Philadelphia where most recently I served as Associate Professor of Medical Oncology as well as Co-Director of the Phase I Program for Hematologic Malignancies.
In these roles, I have developed and led a robust portfolio of clinical research in hematologic malignancies, with a focus on early phase drug development in leukemia and myelodysplastic syndrome.
The diagnosis of a new or relapsed blood cancer can be devastating for patients and families. Often times, hope in these situations comes in the form of promising new therapies leading to a greater chance of cure with fewer side effects. My clinical practice is dedicated to providing patients with the access to the most advanced and specialized care anywhere with the highest level of compassion and empathy.
Acute Leukemias and Myelodysplastic Syndrome
Based on 25 reviews
Gives easy to understand instructions
Spends enough time with you
Shows respect for what you say
Provider listens carefully to you
Provider explains things in way you understand
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.